← Alle mensen

RH

R Herbst

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

EGFR-gemuteerd NSCLC: ESMO expertconsensus

Annals of oncology : official journal of the European Society for Medical Oncology · 2022-05

Intermediaire-dosis cytarabine-mitoxantron versus standaard daunorubicine-cytarabine bij AML: SAL 60+

Annals of oncology : official journal of the European Society for Medical Oncology · 1 april 2018